← Evidence map

ReviewCancer science2022

Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs.

Gérard Milano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

89 papers cite itlatest 60 shown

2022
…
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35445479